| MolName | (Z)-3-[3-[3-(azepan-1-ylsulfonyl)phenyl]-1-phenylpyrazol-4-yl]-2-(morpholine-4-carbonyl)prop-2-enenitrile |
| MolecularFormula | C29H31N5O4S |
| Smiles | N#C/C(/C(N1CCOCC1)=O)=C/c1cn(-c2ccccc2)nc1-c1cccc(S(N2CCCCCC2)(=O)=O)c1 |
| InChI | InChI=1S/C29H31N5O4S/c30-21-24(29(35)32-15-17-38-18-16-32)19-25-22-34(26-10-4-3-5-11-26)31-28(25)23-9-8-12-27(20-23)39(36,37)33-13-6-1-2-7-14-33/h3-5,8-12,19-20,22H,1-2,6-7,13-18H2 |
| InChIK | NVPGYEXLOFNCTN-UHFFFAOYSA-N |
| TotalMolweight | 545.662 |
| Molweight | 545.662 |
| MonoisotopicMass | 545.209675 |
| CLogP | 2.9829 |
| CLogS | -3.846 |
| H Acceptors | 9 |
| TotalSurfaceArea | 414.69 |
| Relative PSA | 0.21732 |
| PolarSurfaceArea | 116.91 |
| Druglikeness | -5.8908 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.4359 |
| Fragments | 1 |
| Non HAtoms | 39 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 5 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 12 |
| Symmetricatoms | 8 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (Z)-3-[3-[3-(azepan-1-ylsulfonyl)phenyl]-1-phenylpyrazol-4-yl]-2-(morpholine-4-carbonyl)prop-2-enenitrile | 2 - (Z)-3-[3-[3-(azepan-1-ylsulfonyl)phenyl]-1-phenylpyrazol-4-yl]-2-(morpholine-4-carbonyl)prop-2-enenitrile